Achillion Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
5 Stocks That Pushed Russell 2000 ETF Higher
Article By: Sweta Killa
Wednesday, November 27, 2019 6:43 PM EST
Though most stocks in the fund’s portfolio are moving north this year, here are the five best-performing stocks in the ETF that have led the way higher.
In this article: ACHN, EVER, EVER, CFMS, APPS, KOD Also: IWM
Read
Alexion To Acquire Achillion Pharma For $930M
Article By: Benzinga
Wednesday, October 16, 2019 9:06 AM EST
Alexion Pharma will buy Achillion Pharma for the initial value of $930 million, or $6.30 per share in cash plus added contingent considerations for a total potential value of $8.30 per share.
In this article: ALXN, ACHN
Read
Achillion Pharmaceuticals Shares Shoot Up On Positive Trial Results
Article By: TickerTV
Wednesday, August 9, 2017 10:52 AM EST
ACHN opened trading yesterday at $4.00 which was up from the previous day’s trading close of $3.97. ACHN closed trading yesterday at $4.01 and spiked up after market to $5.12, equivalent to a 28% increase from the closing price.
In this article: ACHN
Read
Biotech Digest – JAZZ Reports Positive Results, CTSO Inks New Contract, AMGN Forges Collaboration
Article By: KKD Healthcare Analytics
Tuesday, April 25, 2017 10:15 AM EST
Capricor Therapeutics announced encouraging six-month results in a Phase 1/2 clinical trial. Jazz Pharmaceuticals reported results from its Phase 2/3 clinical trial. Amgen announced its new collaboration with Novartis.
In this article: NVS, EAPH, ACHN, JAZZ, AMGN, CANF, CAPR, CTSO
Read
EC Will These 5 Drug Stocks Be Big Winners This Earnings Season?
Article By: Arpita Dutt
Thursday, October 13, 2016 10:54 AM EST
With the Medical sector expected to record earnings and revenue growth, it makes sense to select stocks from this sector that performed well in Q2 and are expected to do well in Q3.
In this article: ACHN, ARIA, EXEL, UTHR, ASND
Read

PARTNER HEADLINES

Latest Tweets for $ACHN

No tweets yet!